Analysis of Proteomic Biomarkers for Acute Interstitial Lung Disease (ILD) in Gefitinib-Treated Japanese Non-Small Cell Lung Cancer (NSCLC) Patients

被引：0
|
作者：
Nyberg, Fredrik [1 ,2 ]
Ogiwara, Atsushi [3 ,4 ]
Harbron, Chris G. [5 ]
Kawakami, Takao [3 ,4 ,6 ]
Komatsu, Yasuhiko [3 ,4 ]
Nishimura, Toshihide [3 ,4 ,6 ]
Marko-Varga, Gyorgy [7 ]
机构：
[1] AstraZeneca R&D, Epidemiol, Molndal, Sweden
[2] Karolinska Inst, Inst Env Med, Stockholm, Sweden
[3] Med ProteoScope Co Ltd, R&D Div, Tokyo, Japan
[4] Yokohama City Uni, Adv Med Res Ctr, Yokohama, Kanagawa, Japan
[5] AstraZeneca R&D, Discovery Stat, Alderley Pk, Cheshire, England
[6] Tokyo Med Uni, Dep Surg 1, Tokyo, Japan
[7] Lund Uni, Div Clin Prot Sci & Imaging, Biomed Ctr, Lund, Sweden
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
262
引用
收藏
页码：S112 / S113
页数：2
相关论文
共 50 条
  • [21] Longitudinal tumor dynamic modeling in non-small cell lung cancer (NSCLC) patients treated with gefitinib
    Xu, Hongmei
    Zhou, Diansong
    Tong, Xiao
    Al-Huniti, Nidal
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S39 - S39
  • [22] EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer
    Kimura, Hideharu
    Kasahara, Kazuo
    Shibata, Kazuhiko
    Sone, Takashi
    Yoshimoto, Akihiro
    Kita, Toshiyuki
    Ichikawa, Yukari
    Waseda, Yuko
    Watanabe, Kazuyoshi
    Shiarasaki, Hiroki
    Ishiura, Yoshihisa
    Mizuguchi, Masayuki
    Nakatsumi, Yasuto
    Kashii, Tatsuhiko
    Kobayashi, Masashi
    Kunitoh, Hideo
    Tamura, Tomohide
    Nishio, Kazuto
    Fujimura, Masaki
    Nakao, Shinji
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (03) : 260 - 267
  • [23] Epidermal growth factor receptor mutations in Greek gefitinib-treated non-small-cell lung cancer (NSCLC) patients
    Voutsina, A
    Pallis, AG
    Souglakos, J
    Koutsopoulos, A
    Kalykaki, A
    Trypaki, M
    Mavroudis, D
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2006, 17 : 42 - 42
  • [24] POOR PROGNOSTIC FACTORS FOR INTERSTITIAL LUNG DISEASE (ILD)-RELATED DEATH IN JAPANESE NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS IN THE POLARSTAR STUDY
    Inoue, Yoshikazu
    Ando, Masahiko
    Ohe, Yuichiro
    Nakagawa, Kazuhiko
    Yamazaki, Naoya
    Arakawa, Hiroaki
    Ebina, Masahito
    Kuwano, Kazuyoshi
    Kusumoto, Masahiko
    Gemma, Akihiko
    Sakai, Fumikazu
    Johkoh, Takeshi
    Taniguchi, Hiroyuki
    Fukuda, Yuh
    Seki, Akihiro
    Fukuoka, Masahiro
    Kudoh, Shoji
    RESPIROLOGY, 2013, 18 : 41 - 41
  • [25] Acute Respiratory Failure Developed in Non-small Cell Lung Cancer Patients Treated With Gefitinib
    Ryu, Jeong-Seon
    Kim, Lucia
    Kim, Chul-Hyun
    Kim, Hyun-Jung
    Cho, Jae-Hwa
    Kwak, Seung-Min
    Lee, Hong-Lyeol
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2007, 62 (02) : 144 - 148
  • [26] PEMETREXED MONOTHERAPY FOR JAPANESE PATIENTS WITH PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (NSCLC)
    Sato, Akira
    Misumi, Yuki
    Kashizaki, Fumihiro
    Ishii, Mari
    Shimokawa, Tsuneo
    Hida, Naoya
    Okamoto, Hiroaki
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1213 - S1214
  • [27] EGFR genomic gain in Japanese non-small cell lung cancer patients treated with gefitinib.
    Varella-Garcia, M.
    Mitsudomi, T.
    Yatabe, Y.
    Kosaka, T.
    Nakajima, E.
    Franklin, W.
    Bunn, P. A., Jr.
    Hirsch, F. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 405S - 405S
  • [28] Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib
    Takano, T
    Ohe, Y
    Kusumoto, M
    Tateishi, U
    Yamamoto, S
    Nokihara, H
    Yamamoto, N
    Sekine, I
    Kunitoh, H
    Tamura, T
    Kodama, T
    Saijo, N
    LUNG CANCER, 2004, 45 (01) : 93 - 104
  • [29] ILD-NSCLC-GAP index scoring and staging system for patients with non small cell lung cancer and interstitial lung disease
    Kobayashi, Haruki
    Naito, Tateaki
    Omae, Katsuhiro
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Ono, Akira
    Kenmotsu, Hirotsugu
    Murakami, Haruyasu
    Endo, Masahiro
    Takahashi, Toshiaki
    LUNG CANCER, 2018, 121 : 48 - 53
  • [30] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    LUNG CANCER, 2007, 55 (01) : 125 - 127
12345